相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Targeting the PD-1 pathway: a promising future for the treatment of melanoma
Andrew Mamalis et al.
ARCHIVES OF DERMATOLOGICAL RESEARCH (2014)
Phase I trial of a recombinant yeast-CEA vaccine (GI-6207) in adults with metastatic CEA-expressing carcinoma
Marijo Bilusic et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2014)
TLR4 is essential for dendritic cell activation and anti-tumor T-cell response enhancement by DAMPs released from chemically stressed cancer cells
Hongliang Fang et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2014)
Gemcitabine, Oxaliplatin, Levofolinate, 5-Fluorouracil, Granulocyte-Macrophage Colony-Stimulating Factor, and Interleukin-2 (GOLFIG) Versus FOLFOX Chemotherapy in Metastatic Colorectal Cancer Patients: The GOLFIG-2 Multicentric Open-label Randomized Phase III Trial
Pierpaolo Correale et al.
JOURNAL OF IMMUNOTHERAPY (2014)
CTLA-4 Blockade Enhances Antitumor Immunity of Intratumoral Injection of Immature Dendritic Cells into Irradiated Tumor in a Mouse Colon Cancer Model
Cheol-Hun Son et al.
JOURNAL OF IMMUNOTHERAPY (2014)
Panitumumab versus cetuximab in patients with chemotherapy-refractory wild-type KRAS exon 2 metastatic colorectal cancer (ASPECCT): a randomised, multicentre, open-label, non-inferiority phase 3 study
Timothy J. Price et al.
LANCET ONCOLOGY (2014)
Bevacizumab exposure beyond first disease progression in patients with metastatic colorectal cancer: analyses of the ARIES observational cohort study
Axel Grothey et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2014)
Immune Escape Mechanisms in Colorectal Cancer Pathogenesis and Liver Metastasis
Massimo Pancione et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2014)
Early BCR events and antigen captutre, processing, and loading on MHC class II on B cells
Ana M. Avelos et al.
FRONTIERS IN IMMUNOLOGY (2014)
Organizing MHC class II presentation
David R. Fooksman
FRONTIERS IN IMMUNOLOGY (2014)
Size of metastatic deposits affects prognosis in patients undergoing pulmonary metastectomy for colorectal cancer
M. A. Javed et al.
ANNALS OF THE ROYAL COLLEGE OF SURGEONS OF ENGLAND (2014)
A Randomized Phase II Study of Immunization With Dendritic Cells Modified With Poxvectors Encoding CEA and MUC1 Compared With the Same Poxvectors Plus GM-CSF for Resected Metastatic Colorectal Cancer
Michael A. Morse et al.
ANNALS OF SURGERY (2013)
Cancer immunoediting: antigens, mechanisms, and implications to cancer immunotherapy
Matthew D. Vesely et al.
RENAISSANCE OF CANCER IMMUNOTHERAPY (2013)
Nanoparticles-based multi-adjuvant whole cell tumor vaccine for cancer immunotherapy
Shi-Ying Liu et al.
BIOMATERIALS (2013)
The Role of Interleukin-17A in Colorectal Tumorigenesis
Yingpeng Shi et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2013)
CD169-positive macrophages in regional lymph nodes are associated with a favorable prognosis in patients with colorectal carcinoma
Koji Ohnishi et al.
CANCER SCIENCE (2013)
Simultaneous blockade of programmed death 1 and vascular endothelial growth factor receptor 2 (VEGFR2) induces synergistic anti-tumour effect in vivo
S. Yasuda et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2013)
Defective Generation and Maturation of Dendritic Cells from Monocytes in Colorectal Cancer Patients during the Course of Disease
Giulia Orsini et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
A critical review of the role of Fc gamma receptor polymorphisms in the response to monoclonal antibodies in cancer
James D. Mellor et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2013)
Peptide Vaccines and Peptidomimetics of EGFR (HER-1) Ligand Binding Domain Inhibit Cancer Cell Growth In Vitro and In Vivo
Kevin Chu Foy et al.
JOURNAL OF IMMUNOLOGY (2013)
Fc-gamma receptor polymorphisms as predictive and prognostic factors in patients receiving oncolytic adenovirus treatment
Mari Hirvinen et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2013)
Panitumumab-FOLFOX4 Treatment and RAS Mutations in Colorectal Cancer
Jean-Yves Douillard et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Efficacy and Safety of Bevacizumab in Metastatic Colorectal Cancer: Pooled Analysis From Seven Randomized Controlled Trials
Herbert I. Hurwitz et al.
ONCOLOGIST (2013)
Prognostic and Clinicopathological Significance of Survivin in Colorectal Cancer: A Meta-Analysis
Andreas Krieg et al.
PLOS ONE (2013)
Enhanced antitumor efficacy by combination treatment with a human umbilical vein endothelial cell vaccine and a tumor cell lysate-based vaccine
Maolei Xu et al.
TUMOR BIOLOGY (2013)
Prognostic value of innate and adaptive immunity in colorectal cancer
Fabio Grizzi et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
Immunotherapy for colorectal cancer
Shigeo Koido et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
Dendritic Cells: Master Regulators of the Immune Response
Ira Mellman
CANCER IMMUNOLOGY RESEARCH (2013)
Fusions between dendritic cells and whole tumor cells as anticancer vaccines
Shigeo Koido et al.
ONCOIMMUNOLOGY (2013)
Correlation Between Auto-antibodies to Survivin and MUC1 Variable Number Tandem Repeats in Colorectal Cancer
Yu-Qian Wang et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2012)
CTLA-4 Blockade with Ipilimumab: Long-term Follow-up of 177 Patients with Metastatic Melanoma
Peter A. Prieto et al.
CLINICAL CANCER RESEARCH (2012)
Recent Advances in Active Specific Cancer Vaccine Treatment for Colorectal Cancer
Kiyotaka Okuno et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2012)
Fc gamma receptor polymorphisms as predictive markers of Cetuximab efficacy in epidermal growth factor receptor downstream-mutated metastatic colorectal cancer
Javier Rodriguez et al.
EUROPEAN JOURNAL OF CANCER (2012)
Interleukin-6-A Key Regulator of Colorectal Cancer Development
Maximilian J. Waldner et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2012)
Induction of IgM, IgA and IgE Antibodies in Colorectal Cancer Patients Vaccinated with a Recombinant CEA Protein
Caroline Staff et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2012)
Addition of Aflibercept to Fluorouracil, Leucovorin, and Irinotecan Improves Survival in a Phase III Randomized Trial in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen
Eric Van Cutsem et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Expression of tumour-specific antigens underlies cancer immunoediting
Michel DuPage et al.
NATURE (2012)
Safety and Activity of Anti-PD-L1 Antibody in Patients with Advanced Cancer
Julie R. Brahmer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Carcinoembryonic Antigen (CEA)-Based Cancer Vaccines: Recent Patents and Antitumor Effects from Experimental Models to Clinical Trials
Mario Turriziani et al.
RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY (2012)
Whole Cell Vaccines-Past Progress and Future Strategies
Bridget P. Keenan et al.
SEMINARS IN ONCOLOGY (2012)
Myeloid-Derived Suppressor Cells: General Characteristics and Relevance to Clinical Management of Pancreatic Cancer
P. Goedegebuure et al.
CURRENT CANCER DRUG TARGETS (2011)
Cetuximab Plus Irinotecan, Fluorouracil, and Leucovorin As First-Line Treatment for Metastatic Colorectal Cancer: Updated Analysis of Overall Survival According to Tumor KRAS and BRAF Mutation Status
Eric Van Cutsem et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
S100A8/A9 Activate Key Genes and Pathways in Colon Tumor Progression
Mie Ichikawa et al.
MOLECULAR CANCER RESEARCH (2011)
Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma
Caroline Robert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Evaluation of immunological escape mechanisms in a mouse model of colorectal liver metastases
Martin Grimm et al.
BMC CANCER (2010)
A pilot study on the immunogenicity of dendritic cell vaccination during adjuvant oxaliplatin/capecitabine chemotherapy in colon cancer patients
W. J. Lesterhuis et al.
BRITISH JOURNAL OF CANCER (2010)
Intratumoral CD8+ T/FOXP3+ cell ratio is a predictive marker for survival in patients with colorectal cancer
Hiroyuki Suzuki et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2010)
Evaluation of the immunogenicity of a single chain chimeric peptide composed of hCGβ and oLHα for inhibition of the growth of hCGβ-expressing cancer cells
Chu Jiang et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2010)
Clinical significance and regulation of the costimulatory molecule B7-H3 in human colorectal carcinoma
Jing Sun et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2010)
Simultaneous Blockade of Multiple Immune System Inhibitory Checkpoints Enhances Antitumor Activity Mediated by Interleukin-15 in a Murine Metastatic Colon Carcinoma Model
Ping Yu et al.
CLINICAL CANCER RESEARCH (2010)
A Randomized Trial of Ex vivo CD40L Activation of a Dendritic Cell Vaccine in Colorectal Cancer Patients: Tumor-Specific Immune Responses Are Associated with Improved Survival
Richard J. Barth et al.
CLINICAL CANCER RESEARCH (2010)
Epitope Discovery and Their Use in Peptide Based Vaccines
Nadine L. Dudek et al.
CURRENT PHARMACEUTICAL DESIGN (2010)
Cytokine treatment of macrophage suppression of T cell activation
Daniel Silberman et al.
IMMUNOBIOLOGY (2010)
Origin and development of dendritic cells
Kang Liu et al.
IMMUNOLOGICAL REVIEWS (2010)
EGFR Antibodies in Colorectal Cancer: Where Do They Belong?
Axel Grothey
JOURNAL OF CLINICAL ONCOLOGY (2010)
Phase I Study of Intravenous Vascular Endothelial Growth Factor Trap, Aflibercept, in Patients With Advanced Solid Tumors
A. Craig Lockhart et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Randomized, Phase III Trial of Panitumumab With Infusional Fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX4) Versus FOLFOX4 Alone As First-Line Treatment in Patients With Previously Untreated Metastatic Colorectal Cancer: The PRIME Study
Jean-Yves Douillard et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Cetuximab in metastatic colorectal cancer
Ido Wolf et al.
LANCET ONCOLOGY (2010)
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
F. Stephen Hodi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer.
Philip W. Kantoff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Enhancing immune responses to tumor-associated antigens
Jack P. Higgins et al.
CANCER BIOLOGY & THERAPY (2009)
Induction of p53-Specific Immunity by a p53 Synthetic Long Peptide Vaccine in Patients Treated for Metastatic Colorectal Cancer
Frank M. Speetjens et al.
CLINICAL CANCER RESEARCH (2009)
Guidelines for the Evaluation of Immune Therapy Activity in Solid Tumors: Immune-Related Response Criteria
Jedd D. Wolchok et al.
CLINICAL CANCER RESEARCH (2009)
Adjuvant Therapy With the Monoclonal Antibody Edrecolomab Plus Fluorouracil-Based Therapy Does Not Improve Overall Survival of Patients With Stage III Colon Cancer
Anthony L. A. Fields et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Fluorouracil, Leucovorin, and Oxaliplatin With and Without Cetuximab in the First-Line Treatment of Metastatic Colorectal Cancer
Carsten Bokemeyer et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Myeloid-Derived Suppressor Cells: Linking Inflammation and Cancer
Suzanne Ostrand-Rosenberg et al.
JOURNAL OF IMMUNOLOGY (2009)
Cetuximab and panitumumab: are they interchangeable?
Richard Kim
LANCET ONCOLOGY (2009)
Targeting angiogenesis: progress with anti-VEGF treatment with large molecules
Axel Grothey et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2009)
Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer
Eric Van Cutsem et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
The Clinical Benefit of Bevacizumab in Metastatic Colorectal Cancer Is Independent of K-ras Mutation Status: Analysis of a Phase III Study of Bevacizumab with Chemotherapy in Previously Untreated Metastatic Colorectal Cancer
Herbert I. Hurwitz et al.
ONCOLOGIST (2009)
Immunity feedback and clinical outcome in colon cancer patients undergoing chemoimmunotherapy with gemcitabine plus FOLFOX followed by subcutaneous granulocyte macrophage colony-stimulating factor and aldesleukin (GOLFIG-1 trial)
Pierpaolo Correale et al.
CLINICAL CANCER RESEARCH (2008)
Signaling defects in anti-tumor T cells
Alan B. Frey et al.
IMMUNOLOGICAL REVIEWS (2008)
Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer:: A randomized phase III study
Leonard B. Saltz et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Systemic Therapy for Advanced or Metastatic Colorectal Cancer: National Comprehensive Cancer Network Guidelines for Combining Anti-Vascular Endothelial Growth Factor and Anti-Epidermal Growth Factor Receptor Monoclonal Antibodies with Chemotherapy
Paul F. Engstrom
PHARMACOTHERAPY (2008)
Modes of resistance to anti-angiogenic therapy
Gabriele Bergers et al.
NATURE REVIEWS CANCER (2008)
Tumor-infiltrating macrophages and dendritic cells in human colorectal cancer: relation to local regulatory T cells, systemic T-cell response against tumor-associated antigens and survival
Dirk Nagorsen et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2007)
Vaccination of metastatic colorectal cancer patients with matured dendritic cells loaded with multiple major histocompatibility complex class I peptides
Brian Kavanagh et al.
JOURNAL OF IMMUNOTHERAPY (2007)
Pulmonary resection for metastases from colorectal cancer: prognostic factors and survival
Won-Suk Lee et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2007)
A novel dendritic cell-based cancer vaccine produces promising results in a syngenic CC-36 murine colon adenocarcinoma model
Angela M. Jack et al.
JOURNAL OF SURGICAL RESEARCH (2007)
A cytokine-mediated link between innate immunity, inflammation, and cancer
Wan-Wan Lin et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Successful cancer vaccine therapy for carcinoembryonic antigen (CEA)-expressing colon cancer using genetically modified dendritic cells that express CEA and T helper-type I cytokines in CEA transgenic mice
Toshiyasu Ojima et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
A neoadjuvant/adjuvant randomized trial of colorectal cancer patients vaccinated with an anti-idiotypic antibody, 105AD7, mimicking CD55
Gustav J. Ullenhag et al.
CLINICAL CANCER RESEARCH (2006)
Towards a pan-European consensus on the treatment of patients with colorectal liver metastases
Eric Van Cutsem et al.
EUROPEAN JOURNAL OF CANCER (2006)
Vaccination of colorectal cancer patients with CEA-loaded dendritic cells: antigen-specific T cell responses in DTH skin tests
W. J. Lesterhuis et al.
ANNALS OF ONCOLOGY (2006)
CTL adoptive immunotherapy concurrently mediates tumor regression and tumor escape
Kebin Liu et al.
JOURNAL OF IMMUNOLOGY (2006)
Effector memory T cells, early metastasis, and survival in colorectal cancer
F Pagès et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
The role of bevacizumab as first-line therapy for colon cancer
J Marshall
SEMINARS IN ONCOLOGY (2005)
Human dendritic cells: Potent antigen-presenting cells at the crossroads of innate and adaptive immunity
M Rossi et al.
JOURNAL OF IMMUNOLOGY (2005)
CD8+ T-cell response against MUC1-derived peptides in gastrointestinal cancer survivors
J Dittmann et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2005)
WT1 is a tumor-associated antigen in colon cancer that can be recognized by in vitro stimulated cytotoxic T cells
R Koesters et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
A novel human cancer vaccine elicits cellular responses to the tumor-associated antigen, human chorionic gonadotropin β
LZ He et al.
CLINICAL CANCER RESEARCH (2004)
FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer:: A randomized GERCOR study
C Tournigand et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Regulatory T cells and mechanisms of immune system control
A O'Garra et al.
NATURE MEDICINE (2004)
Colorectal cancer vaccines: Principles, results, and perspectives
S Mocellin et al.
GASTROENTEROLOGY (2004)
Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer
H Hurwitz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Regulatory T cells: Friend or foe in immunity to infection?
KHG Mills
NATURE REVIEWS IMMUNOLOGY (2004)
CEA, CA 242, CA 19-9, CA 72-4 and hCG beta in the diagnosis of recurrent colorectal cancer
M Carpelan-Holmstrom et al.
TUMOR BIOLOGY (2004)
XELOX (capecitabine plus oxaliplatin):: Active first-line therapy for patients with metastatic colorectal cancer
J Cassidy et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Phase I immunotherapy with a modified vaccinia virus (MVA) expressing human MUC1 as antigen-specific immunotherapy in patients with MUC1-positive advanced cancer
C Rochlitz et al.
JOURNAL OF GENE MEDICINE (2003)
Overexpression of the Wilms' tumor gene WT1 in colorectal adenocarcinoma
Y Oji et al.
CANCER SCIENCE (2003)
Immunodeficiency and cancer: prospects for correction
JW Hadden
INTERNATIONAL IMMUNOPHARMACOLOGY (2003)
Safety of intravenous administration of a canarypox virus encoding the human wild-type p53 gene in colorectal cancer patients
AG Menon et al.
CANCER GENE THERAPY (2003)
VEGF inhibits T-cell development and may contribute to tumor-induced immune suppression
JE Ohm et al.
BLOOD (2003)
Application of autologous tumor cell vaccine and NDV vaccine in treatment of tumors of digestive traet
W Liang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2003)
Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer
L Zhang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Intrinsic differences in the proliferation of naive and memory human B cells as a mechanism for enhanced secondary immune responses
SG Tangye et al.
JOURNAL OF IMMUNOLOGY (2003)
Trends in long-term survival following liver resection for hepatic colorectal metastases
MA Choti et al.
ANNALS OF SURGERY (2002)
Expression of tumor rejection antigens in colorectal carcinomas
T Sasatomi et al.
CANCER (2002)
Tumor-induced death of immune cells: its mechanisms and consequences
TL Whiteside
SEMINARS IN CANCER BIOLOGY (2002)
T-cell-directed cancer vaccines: mechanisms of immune escape and immune tolerance
GQ Phan et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2001)
Mannan mucin-1 peptide immunization: Influence of cyclophosphamide and the route of injection
V Karanikas et al.
JOURNAL OF IMMUNOTHERAPY (2001)
CD55 is over-expressed in the tumour environment
L Li et al.
BRITISH JOURNAL OF CANCER (2001)
Phase I clinical trial of a recombinant canarypoxvirus (ALVAC) vaccine expressing human carcinoembryonic antigen and the B7.1 co-stimulatory molecule
H Hörig et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2000)
Advances in immunology: Innate immunity.
R Medzhitov et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Advances in immunology: The immune system - Second of two parts.
PJ Delves et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Dendritic cell-based cancer immunotherapy: Potential for treatment of colorectal cancer?
WX Chen et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2000)
Adjuvant active specific immunotherapy for stage II and III colon cancer with an autologous tumor cell vaccine: Eastern Cooperative Oncology Group study E5283
JE Harris et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
分享论文
